AVADEL PHARMACEUTICALS PLC — Director's Dealing 2017

Sep 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2017-09-21

Reporting Person: Thornton Peter J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-21	ADSs	P	5155	$9.741	Acquired	5155	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$10.51	2022-06-28	ADSs (30000)	30000	Direct

Footnotes

F1: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

F2: Options become exercisable as to all 30,000 ADSs on the first anniversary of the 06/28/2017 grant date.